ANNETTE DAVIS: Open Payments
NPI 1437815214 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 34 payments from 14 companies in 2025. Trend: 2023 $854 · 2024 $135 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $230 |
| Edwards Lifesciences Corporation | 2 | $162 |
| Amgen Inc. | 10 | $137 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $60 |
| Aimmune Therapeutics, Inc. | 3 | $51 |
| ABBVIE INC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| KYOWA KIRIN, INC. | 1 | $28 |
| Corcept Therapeutics | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: SAPIEN 3 Ultra RESILIA, Wegovy, Ozempic, EVENITY, XIFAXAN, ZENPEP, QULIPTA, OTEZLA.
Industry payments across AZ — which companies pay providers there.
